Scott J Tebbutt
Overview
Explore the profile of Scott J Tebbutt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
1760
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Kim Y, Tebbutt S, Singh A
Int J Rheum Dis
. 2024 Dec;
28(1):e70039.
PMID: 39740063
No abstract available.
3.
He D, Shannon C, Hirota J, Ask K, Ryerson C, Tebbutt S
PLoS One
. 2024 Dec;
19(12):e0314876.
PMID: 39625896
Fibrotic interstitial lung diseases (ILDs) result from excessive deposition of extracellular matrix (ECM) proteins in the lung, causing irreversible damage to the lung architecture. Clinical management of ILDs differs depending...
4.
He D, Guler S, Shannon C, Ryerson C, Tebbutt S
Eur Respir J
. 2024 Nov;
PMID: 39603671
Objective: Gene expression (transcriptomics) studies have revealed potential mechanisms of interstitial lung disease (ILD), yet sample sizes of studies are often limited and between-subtype comparisons are scarce. The aim of...
5.
6.
7.
An A, Acton E, Idoko O, Shannon C, Blimkie T, Falsafi R, et al.
EBioMedicine
. 2024 Oct;
110:105411.
PMID: 39472236
Background: Neonatal sepsis is a deadly disease with non-specific clinical signs, delaying diagnosis and treatment. There remains a need for early biomarkers to facilitate timely intervention. Our objective was to...
8.
Multi-level insights into the immuno-oncology-microbiome axis: From biotechnology to novel therapies
Pi Z, Liu W, Song C, Zhu C, Liu J, Wang L, et al.
Imeta
. 2024 Oct;
3(5):e240.
PMID: 39429874
The multifaceted interactions among the immune system, cancer cells and microbial components have established a novel concept of the immuno-oncology-microbiome (IOM) axis. Microbiome sequencing technologies have played a pivotal role...
9.
10.
Martino D, Kresoje N, Amenyogbe N, Ben-Othman R, Cai B, Lo M, et al.
Nat Commun
. 2024 Sep;
15(1):8167.
PMID: 39289350
Understanding of newborn immune ontogeny in the first week of life will enable age-appropriate strategies for safeguarding vulnerable newborns against infectious diseases. Here we conducted an observational study exploring the...